Previous studies had identified SEMA4D and VEGF had a positive correlation in EOC cancer tissues and knockdown of VEGF could suppress SEMA4D expression, which indicate poor prognosis for EOC patients (9, 10). This evidence concerns the gene SEMA4D and cancer.